AACE AME ETA甲状腺结节诊治指南.docx
- 文档编号:7296564
- 上传时间:2023-01-22
- 格式:DOCX
- 页数:25
- 大小:4.12MB
AACE AME ETA甲状腺结节诊治指南.docx
《AACE AME ETA甲状腺结节诊治指南.docx》由会员分享,可在线阅读,更多相关《AACE AME ETA甲状腺结节诊治指南.docx(25页珍藏版)》请在冰豆网上搜索。
AACEAMEETA甲状腺结节诊治指南
AACE/AME/ETAThyroidNoduleGuidelines,EndocrPract.2010;16(Suppl141controlledclinicalstudy.NEnglJMed.1987;317:
70-75.[EL1]121.LaRosaGL,IppolitoAM,LupoL,etal.ColdthyroidnodulereductionwithL-thyroxinecanbepredictedbyinitialnodulevolumeandcytologicalcharacteristics.JClinEndocrinolMetab.1996;81:
4385-4387.[EL2]122.PapiniE,PetrucciL,GuglielmiR,etal.Long-termchangesinnodulargoiter:
a5-yearprospectiverandomizedtrialoflevothyroxinesuppressivetherapyforbenigncoldthyroidnodules.JClinEndocrinolMetab.1998;83:
780783.[EL1]123.WemeauJL,CaronP,SchvartzC,etal.Effectsofthyroid-stimulatinghormonesuppressionwithlevothyroxineinreducingthevolumeofsolitarythyroidnodulesandimprovingextranodularnonpalpablechanges:
arandomized,double-blind,placebo-controlledtrialbytheFrenchThyroidResearchGroup.JClinEndocrinolMetab.2002;87:
4928-4934.[EL 1]124.HegedusL,NygaardB,HansenJM.Isroutinethyroxinetreatmenttohinderpostoperativerecurrenceofnontoxicgoiterjustified?
JClinEndocrinolMetab.1999;84:
756760.[EL2]125.MoalemJ,SuhI,DuhQY.Treatmentandpreventionofrecurrenceofmultinodulargoiter:
anevidence-basedreviewoftheliterature.WorldJSurg.2008;32:
1301-1312.[EL4]126.FaberJ,GalloeAM.ChangesinbonemassduringprolongedsubclinicalhyperthyroidismduetoL-thyroxinetreatment:
ameta-analysis.EurJEndocrinol.1994;130:
350-356.[EL1]127.UzzanB,CamposJ,CucheratM,NonyP,BoisselJP,PerretGY.Effectsonbonemassoflongtermtreatmentwiththyroidhormones:
Ameta-analysis.JClinEndocrinolMetab.1996;81:
4278-4289.[EL1]128.SawinCT,GellerA,WolfPA,etal.Lowserumthyrotropinconcentrationsasariskfactorforatrialfibrillationinolderpersons.NEnglJMed.1994;331:
1249-1252.[EL2]129.ParleJV,MaisonneuveP,SheppardMC,BoyleP,FranklynJA.Predictionofall-causeandcardiovascularmortalityinelderlypeoplefromonelowserumthyrotropinresult:
A10-yearcohortstudy.Lancet.2001;358:
861-865.[EL2]130.LaRosaGL,LupoL,GiuffridaD,GulloD,VigneriR,BelfioreA.Levothyroxineandpotassiumiodidearebotheffectiveintreatingbenignsolitarysolidcoldnodulesofthethyroid.AnnInternMed.1995;122:
1-8.[EL2]131.MiccoliP,MinutoMN,UgoliniC,PisanoR,FossoA,BertiP.Minimallyinvasivevideo-assistedthyroidectomyforbenignthyroiddisease:
Anevidence-basedreview.WorldJSurg.2008;32:
1333-1340.[EL4—review]132.AlvaradoR,McMullenT,SidhuSB,DelbridgeLW,SywakMS.Minimallyinvasivethyroidsurgeryforsinglenodules:
anevidence-basedreviewofthelateralmini-incisiontechnique.WorldJSurg.2008;32:
1341-1348.[EL4—review]133.LivraghiT,ParacchiA,FerrariC,etal.Treatmentofautonomousthyroidnoduleswithpercutaneousethanolinjection:
preliminaryresults:
workinprogress.Radiology.1990;175:
827-829.[EL4]134.PacellaCM,BizzarriG,GuglielmiR,etal.Thyroidtissue:
US-guidedpercutaneousinterstitiallaserablation:
afeasibilitystudy.Radiology.2000;217:
673-677.[EL3]135.VerdeG,PapiniE,PacellaCM,etal.Ultrasoundguidedpercutaneousethanolinjectioninthetreatmentofcysticthyroidnodules.ClinEndocrinol(Oxf.1994;41:
719-724.[EL1]136.GuglielmiR,PacellaCM,BianchiniA,etal.Percutaneousethanolinjectiontreatmentinbenignthyroidlesions:
roleandefficacy.Thyroid.2004;14:
125-131.[EL2]137.ValcaviR,FrasoldatiA.Ultrasound-guidedpercutaneousethanolinjectiontherapyinthyroidcysticnodules.EndocrPract.2004;10:
269-275.[EL3]138.KimJH,LeeHK,LeeJH,AhnIM,ChoiCG.Efficacyofsonographicallyguidedpercutaneousethanolinjectionfortreatmentofthyroidcystsversussolidthyroidnodules.AJRAmJRoentgenol.2003;180:
1723-1726.[EL3]139.ZingrilloM,TorlontanoM,ChiarellaR,etal.Percutaneousethanolinjectionmaybeadefinitivetreatmentforsymptomaticthyroidcysticnodulesnottreatablebysurgery:
Five-yearfollow-upstudy.Thyroid.1999;9:
763-767.[EL3]140.BennedbaekFN,HegedusL.Treatmentofrecurrentthyroidcystswithethanol:
Arandomizeddouble-blindcontrolledtrial.JClinEndocrinolMetab.2003;88:
5773-5777.[EL1]141.LippiF,FerrariC,ManettiL,etal;theMulticenterStudyGroup.Treatmentofsolitaryautonomousthyroidnodulesbypercutaneousethanolinjection:
ResultsofanItalianmulticenterstudy.JClinEndocrinolMetab.1996;81:
32613264.[EL3]142.LivraghiT,ParacchiA,FerrariC,ReschiniE,MacchiRM,BonifacinoA.Treatmentofautonomousthyroidnoduleswithpercutaneousethanolinjection:
4-yearexperience.Radiology.1994;190:
529-533.[EL3]143.ZingrilloM,ColluraD,GhiggiMR,NirchioV,TrischittaV.Treatmentoflargecoldbenignthyroidnodulesnoteligibleforsurgerywithpercutaneousethanolinjection.JClinEndocrinolMetab.1998;83:
3905-3907.[EL3]144.BennedbaekFN,NielsenLK,HegedusL.EffectofpercutaneousethanolinjectiontherapyversussuppressivedosesofL-thyroxineonbenignsolitarysolidcoldthyroidnodules:
Arandomizedtrial.JClinEndocrinolMetab.1998;83:
830-835.[EL1]145.KimYS,RhimH,TaeK,ParkDW,KimST.Radiofrequencyablationofbenigncoldthyroidnodules:
Initialclinicalexperience.Thyroid.2006;16:
361-367.[EL4]146.SpieziaS,GarberoglioR,MiloneF,etal.Thyroidnodulesandrelatedsymptomsarestablycontrolledtwoyearsafterradiofrequencythermalablation.Thyroid.2009;19:
219225.[EL3]147.DossingH,BennedbaekFN,HegedusL.Effectofultrasound-guidedinterstitiallaserphotocoagulationonbenignsolitarysolidcoldthyroidnodules:
Oneversusthreetreatments.Thyroid.2006;16:
763-768.[EL3]148.DossingH,BennedbaekFN,HegedusL.Effectofultrasound-guidedinterstitiallaserphotocoagulationonbenignsolitarysolidcoldthyroidnodules:
Arandomisedstudy.EurJEndocrinol.2005;152:
341-345.[EL2]149.PapiniE,GuglielmiR,BizzarriG,etal.Treatmentofbenigncoldthyroidnodules:
Arandomizedclinicaltrialofpercutaneouslaserablationversuslevothyroxinetherapyorfollow-up.Thyroid.2007;17:
229-235.[EL1]150.CakirB,UgrasNS,GulK,ErsoyR,KorukluogluB.Initialreportoftheresultsofpercutaneouslaserablationofbenigncoldthyroidnodules:
Evaluationofhistopathologicalchangesafter2years.EndocrPathol.2009;20:
170-176.[EL 3]151.MeierDA,BrillDR,BeckerDV,etal;SocietyofNuclearMedicine.Procedureguidelinefortherapyofthyroiddiseasewith(131iodine.JNuclMed.2002;43:
856-861.[EL3—guidelines]
42AACE/AME/ETAThyroidNoduleGuidelines,EndocrPract.2010;16(Suppl1152.NygaardB,HegedusL,NielsenKG,UlriksenP,HansenJM.Long-termeffectofradioactiveiodineonthyroidfunctionandsizeinpatientswithsolitaryautonomouslyfunctioningtoxicthyroidnodules.ClinEndocrinol(Oxf.1999;50:
197-202.[EL3]153.DietleinM,DresslerJ,GrunwaldF,etal;DeutscheGesellschaftfürNuklearmedizin.Guidelineforradioiodinetherapyforbenignthyroiddiseases(version4[articleinGerman].Nuklearmedizin.2007;46:
220-223.[EL 4—guidelines]154.ReinersC,SchneiderP.Radioiodinetherapyofthyroidautonomy.EurJNuclMedMolImaging.2002;29(Suppl2:
S471-S478.[EL3]155.MetsoS,JaatinenP,HuhtalaH,AuvinenA,OksalaH,SalmiJ.Increasedcardiovascularandcancermortalityafterradioiodinetreatmentforhyperthyroidism[erratumin:
JClinEndocrinolMetab.2007;92:
4008].JClinEndocrinolMetab.2007;92:
2190-2196.[EL2]156.RonE,DoodyMM,BeckerDV,etal;CooperativeThyrotoxicosisTherapyFollow-upStudyGroup.Cancermortalityfollowingtreatmentforadulthyperthyroidism.JAMA.1998;280:
347-355.[EL3]157.CeccarelliC,BencivelliW,VittiP,GrassoL,PincheraA.Outcomeofradioiodine-131therapyinhyperfunctioningthyroidnodules:
A20years’retrospectivestudy.ClinEndocrinol(Oxf.2005;62:
331-335.[EL3]158.NygaardB,FaberJ,VejeA,HegedisL,HansenJM.Transitionofnodulartoxicgoitertoautoimmunehyperthyroidismtriggeredby131Itherapy.Thyroid.1999;9:
477481.[EL3]159.NygaardB,KnudsenJH,HegedusL,ScientAV,HansenJE.ThyrotropinreceptorantibodiesandGraves’disease,aside-effectof131Itreatmentinpatientswithnontoxicgoiter.JClinEndocrinolMetab.1997;82:
2926-2930.[EL3]160.WallaschofskiH,MullerD,GeorgiP,PaschkeR.InductionofTSH-receptorantibodiesinpatientswithtoxicmultinodulargoitrebyradioiodinetreatment.HormMetabRes.2002;34:
36-39.[EL3]161.VosXG,SmitN,EndertE,BrosschotJF,TijssenJG,WiersingaWM.AgeandstressasdeterminantsoftheseverityofhyperthyroidismcausedbyGraves’diseaseinnewlydiagnosedpatients.EurJEndocrinol.2009;160:
193199.[EL3]162.BonnemaSJ,BennedbaekFN,VejeA,MarvingJ,HegedusL.Propylthiouracilbefore131Itherapyofhyperthyroiddiseases:
effectoncurerateevaluatedbyarandomizedclinicaltrial.JClinEndocrinolMetab.2004;89:
44394444.[EL 2]163.WalterMA,BrielM,Christ-CrainM,etal.Effectsofantithyroiddrugsonradioiodinetreatment:
systematicreviewandmeta-analysisofrandomisedcontrolledtrials.BMJ.2007;334:
514.[EL1]164.WeetmanAP.Radioiodinetreatmentforbenignthyroiddiseases.ClinEndocrinol(Oxf.2007;66:
757-764.[EL4—review]165.HegedusL,HansenBM,KnudsenN,HansenJM.Reductionofsizeofthyroidwithradioactiveiodineinmultinodularnon-toxicgoitre.BMJ.1988;297:
661-662.[EL3]166.NygaardB,HegedusL,GervilM,HjalgrimH,SoeJensenP,HansenJM.Radioiodinetreatmentofmultinodularnon-toxicgoitre.BMJ.1993;307:
828-832.[EL3]167.HuysmansDA,HermusAR,CorstensFH,BarentszJO,KloppenborgPW.Large,compressivegoiterstreatedwithradioiodine.AnnInternMed.1994;121:
757-762.[EL
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- AACE AME ETA甲状腺结节诊治指南 ETA 甲状腺 结节 诊治 指南